Lima, Ana Paula BragaSilva, Glenda Nicioli da2023-10-192023-10-192022LIMA, A. P. B.; SILVA, G. N. da. Long non-coding rna and chemoresistance in bladder cancer – a mini review. Cancer Investigation, v. 41, n. 2, p. 164–172, nov. 2022. Disponível em: <https://www.tandfonline.com/doi/epdf/10.1080/07357907.2022.2146703?needAccess=true&role=button>. Acesso em: 01 ago. 2023.1532-4192http://www.repositorio.ufop.br/jspui/handle/123456789/17619Bladder cancer is the 10th most common cancer worldwide. It is a heterogeneous disease, comprising several tumor subtypes with differences in histology, genomic aberrations, prognosis and sensitivity to anti-cancer treatments. Although the treatment of bladder cancer is based tumor classifications and gradings, patients have different clinical response. In recent years, long non-coding RNAs (lncRNAs) were associated with bladder cancer chemoresistance. Thus, lncRNAs seem to be promising targets in treatment of bladder cancer. This review highlights the recent findings concerning lncRNAs and their relevance to the chemoresistance of bladder cancer. This may provide a basis for exploiting more robust therapeutic approaches in the future.en-USrestritoBladder cancerChemoresistanceArtigo publicado em periodicohttps://www.tandfonline.com/doi/epdf/10.1080/07357907.2022.2146703?needAccess=true&role=buttonhttps://doi.org/10.1080/07357907.2022.2146703